Clinical Trials

180 enrolled 14 charts

Breast Neoplasms

NCT05710328 2026-04-03

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

235 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT05601440 2026-03-27

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

Phase 2 Recruiting

484 enrolled

Breast Neoplasms

NCT04266249 2026-03-23

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

2,175 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT04316117 2026-03-23

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

138 enrolled

Breast Neoplasms

NCT04001829 2026-03-13

Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer

249 enrolled 14 charts

Anatomic Stage I Breast Cancer AJCC v8

NCT05896566 2026-02-24

PREcoopERA

231 enrolled

Breast Neoplasms

NCT04176848 2026-02-18

CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer

15 enrolled 7 charts

Breast Neoplasms

NCT03624543 2026-01-30

CFI-400945 in Patients With Advanced/Metastatic Breast Cancer

51 enrolled

Breast Neoplasms

NCT03283384 2025-09-19

NEOLBC

100 enrolled

Breast Neoplasms

NCT03820063 2025-09-19

TRAIN-3

462 enrolled

Breast Neoplasms

NCT04489173 2025-09-19

TIBET

52 enrolled

Breast Neoplasms

NCT05392608 2025-09-17

SEQUEL-Breast

130 enrolled

Breast Neoplasms, Genetic Diseases, Inborn

NCT01766297 2025-09-09

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Phase 2 Recruiting

132 enrolled

Breast Neoplasms

NCT01758445 2025-09-04

Proton Radiation for Stage II/III Breast Cancer

220 enrolled

Breast Neoplasms, Neoplasms

NCT03644186 2024-12-13

TOUCH

147 enrolled 11 charts

Breast Neoplasms

NCT05710666 2024-08-05

Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)

11 enrolled

HER2-positive Breast Cancer

NCT00036868 2024-03-08

Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer

90 enrolled

Breast Neoplasms

NCT02536742 2024-02-26

PYTHIA

124 enrolled 10 charts

Breast Neoplasms, Neoplasm Metastasis

NCT02954055 2024-02-26

METEORA-II

140 enrolled 11 charts

Breast Neoplasms, Neoplasm Metastasis

NCT05209529 2024-02-23

Chemo-free BRCA-targeted Neoadjuvant Strategy

Phase 2 Withdrawn

Triple Negative Breast Neoplasms

NCT00482755 2024-02-12

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

4 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT03609047 2024-01-24

Appalaches

366 enrolled

Breast Neoplasms

NCT00255788 2023-08-04

Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer

49 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00258375 2023-08-04

OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer

15 enrolled

Breast Neoplasms

NCT01147484 2023-08-04

IND197

47 enrolled

Breast Neoplasms

NCT01656538 2023-08-04

A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer

81 enrolled

Breast Neoplasms

NCT01124695 2023-06-29

Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer

124 enrolled 14 charts

Breast Neoplasms

NCT00002934 2023-06-22

Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ

Phase 2 Terminated

711 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast

NCT00003236 2023-06-18

Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer

Breast Neoplasms

NCT00002826 2023-06-07

Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer

36 enrolled

Breast Neoplasms

NCT03412643 2023-03-06

FB-12

Phase 2 Unknown

64 enrolled

Breast Neoplasms

NCT01597414 2022-11-17

Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1

80 enrolled

Elderly Metastatic Breast Cancer Population

NCT01082211 2022-06-21

Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery

65 enrolled 16 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT03628066 2022-04-20

Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer

24 enrolled

Breast Neoplasms

NCT02296801 2022-01-13

PALLET

307 enrolled 18 charts

Breast Neoplasms

NCT00464646 2021-10-25

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer

105 enrolled 17 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01008150 2021-10-25

Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer

141 enrolled 16 charts

Breast Neoplasms

NCT01705691 2021-10-06

Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer

50 enrolled 14 charts

Breast Neoplasms

NCT00365417 2021-04-13

Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer

45 enrolled 15 charts

Breast Neoplasms

NCT00238316 2020-04-02

Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density

68 enrolled

Breast Neoplasms

NCT00305695 2020-03-24

Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries

160 enrolled 10 charts

BreastGynecologic

Osteoporosis, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT03532087 2020-01-18

PERIDENO

Phase 2 Withdrawn

Breast Neoplasms

NCT02005887 2019-05-29

TREND

51 enrolled 10 charts

Breast Cancer Invasive Nos

NCT01548677 2019-03-13

TREAT-CTC

1,317 enrolled

Breast Neoplasms, Neoplastic Cells, Circulating

NCT00088972 2018-08-10

S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women

Phase 2 Terminated

8 enrolled 5 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast

NCT01485926 2018-08-06

TCHL Phase II

120 enrolled

Breast Neoplasms

NCT00410813 2017-07-02

S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone

85 enrolled 18 charts

Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

NCT00856492 2017-06-27

S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer

215 enrolled 13 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01763710 2016-03-29

neurabrax

60 enrolled